[PDF][PDF] Inflammatory type 2 cDCs acquire features of cDC1s and macrophages to orchestrate immunity to respiratory virus infection

…, MJ van Helden, D Sichien, N Debeuf… - Immunity, 2020 - cell.com
The phenotypic and functional dichotomy between IRF8 + type 1 and IRF4 + type 2 conventional
dendritic cells (cDC1s and cDC2s, respectively) is well accepted; it is unknown how …

Emerging paradigms in type 2 immunity

H Hammad, N Debeuf, H Aegerter… - Annual Review of …, 2022 - annualreviews.org
A principal purpose of type 2 immunity was thought to be defense against large parasites, but
it also functions in the restoration of homeostasis, such as toxin clearance following snake …

Murine models of allergic asthma

E Haspeslagh, N Debeuf, H Hammad… - … : Methods and Protocols, 2017 - Springer
Allergic asthma is a heterogeneous inflammatory lung disease affecting millions of people
worldwide and with a steadily increasing incidence. Mouse models have been of utmost …

Mouse models of asthma

N Debeuf, E Haspeslagh, M van Helden… - Current protocols in …, 2016 - Wiley Online Library
Allergic asthma is a chronic inflammatory disease of the conducting airways characterized
by the presence of allergen‐specific IgE, Th2 cytokine production, eosinophilic airway …

A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19

…, N Vermeulen, S Lameire, N Debeuf… - Science Translational …, 2023 - science.org
Improvements in COVID-19 treatments, especially for the critically ill, require deeper
understanding of the mechanisms driving disease pathology. The complement system is not only a …

[PDF][PDF] Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

…, B Maes, V Bosteels, L Hoste, L Naesens, N Debeuf… - Cell Reports …, 2022 - cell.com
GM-CSF promotes myelopoiesis and inflammation, and GM-CSF blockade is being evaluated
as a treatment for COVID-19-associated hyperinflammation. Alveolar GM-CSF is, however…

[HTML][HTML] Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial

…, SJ Tavernier, L Detalle, T Smart, S Glatt, N Debeuf… - Respiratory …, 2022 - Springer
Background The efficacy and safety of complement inhibition in COVID-19 patients is
unclear. Methods A multicenter randomized controlled, open-label trial. Hospitalized COVID-19 …

The ORMDL3 asthma susceptibility gene regulates systemic ceramide levels without altering key asthma features in mice

N Debeuf, A Zhakupova, R Steiner… - Journal of Allergy and …, 2019 - Elsevier
… Author links open overlay panel Nincy Debeuf MSc a b , Assem Zhakupova PhD c , Regula
Steiner PhD c , Sofie Van Gassen … PAS staining was performed as described by Debeuf et al. …

[HTML][HTML] Fascin actin bundling controls podosome turnover and disassembly while cortactin is involved in podosome assembly by its SH3 domain in THP-1 …

I Van Audenhove, N Debeuf, C Boucherie… - … et Biophysica Acta (BBA …, 2015 - Elsevier
Podosomes are dynamic degrading devices present in myeloid cells among other cell types.
They consist of an actin core with associated regulators, surrounded by an adhesive ring. …

ORMDL3 expression levels have no influence on the activity of serine palmitoyltransferase

A Zhakupova, N Debeuf, M Krols… - The FASEB …, 2016 - Wiley Online Library
ORMDL proteins are believed to be negative regulators of serine palmitoyl transferase (SPT),
which catalyzes the first and rate limiting step in sphingolipid (SL) de novo synthesis. …